EVALUATION OF NOVEL ORAL ANTICOAGULANT PRESCRIPTION PATTERNS IN A TERTIARY CARE CLINIC Article Swipe
Yana Shamiss
,
Pouria Alipour
,
Zahra Azizi
,
Sarah Donegan
,
N. Varah
,
Alona Avoulov
,
S Nath
,
Catherine E. Jansen
,
Sara Tamjidi
,
Susan Morris
,
Hadi Tohidi
,
Howard Lightstone
,
A. Shusterman
,
Yaariv Khaykin
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1016/j.cjca.2019.07.519
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1016/j.cjca.2019.07.519
Related Topics
Concepts
Medicine
Apixaban
Rivaroxaban
Atrial fibrillation
Dabigatran
Internal medicine
Stroke (engine)
Adverse effect
Dosing
Medical prescription
Warfarin
Cardiology
Pharmacology
Mechanical engineering
Engineering
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.cjca.2019.07.519
- http://www.onlinecjc.ca/article/S0828282X19310013/pdf
- OA Status
- bronze
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2979477908
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2979477908Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.cjca.2019.07.519Digital Object Identifier
- Title
-
EVALUATION OF NOVEL ORAL ANTICOAGULANT PRESCRIPTION PATTERNS IN A TERTIARY CARE CLINICWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-10-01Full publication date if available
- Authors
-
Yana Shamiss, Pouria Alipour, Zahra Azizi, Sarah Donegan, N. Varah, Alona Avoulov, S Nath, Catherine E. Jansen, Sara Tamjidi, Susan Morris, Hadi Tohidi, Howard Lightstone, A. Shusterman, Yaariv KhaykinList of authors in order
- Landing page
-
https://doi.org/10.1016/j.cjca.2019.07.519Publisher landing page
- PDF URL
-
https://www.onlinecjc.ca/article/S0828282X19310013/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://www.onlinecjc.ca/article/S0828282X19310013/pdfDirect OA link when available
- Concepts
-
Medicine, Apixaban, Rivaroxaban, Atrial fibrillation, Dabigatran, Internal medicine, Stroke (engine), Adverse effect, Dosing, Medical prescription, Warfarin, Cardiology, Pharmacology, Mechanical engineering, EngineeringTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2979477908 |
|---|---|
| doi | https://doi.org/10.1016/j.cjca.2019.07.519 |
| ids.doi | https://doi.org/10.1016/j.cjca.2019.07.519 |
| ids.mag | 2979477908 |
| ids.openalex | https://openalex.org/W2979477908 |
| fwci | 0.0 |
| type | article |
| title | EVALUATION OF NOVEL ORAL ANTICOAGULANT PRESCRIPTION PATTERNS IN A TERTIARY CARE CLINIC |
| biblio.issue | 10 |
| biblio.volume | 35 |
| biblio.last_page | S117 |
| biblio.first_page | S116 |
| topics[0].id | https://openalex.org/T10065 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9994000196456909 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2705 |
| topics[0].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[0].display_name | Atrial Fibrillation Management and Outcomes |
| topics[1].id | https://openalex.org/T11064 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9678000211715698 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2705 |
| topics[1].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[1].display_name | Antiplatelet Therapy and Cardiovascular Diseases |
| topics[2].id | https://openalex.org/T10285 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.965499997138977 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2724 |
| topics[2].subfield.display_name | Internal Medicine |
| topics[2].display_name | Venous Thromboembolism Diagnosis and Management |
| is_xpac | False |
| apc_list.value | 3520 |
| apc_list.currency | USD |
| apc_list.value_usd | 3520 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.985358476638794 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2780638905 |
| concepts[1].level | 5 |
| concepts[1].score | 0.9107940196990967 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q414462 |
| concepts[1].display_name | Apixaban |
| concepts[2].id | https://openalex.org/C2778661090 |
| concepts[2].level | 4 |
| concepts[2].score | 0.8661466836929321 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q420262 |
| concepts[2].display_name | Rivaroxaban |
| concepts[3].id | https://openalex.org/C2779161974 |
| concepts[3].level | 2 |
| concepts[3].score | 0.7471791505813599 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q815819 |
| concepts[3].display_name | Atrial fibrillation |
| concepts[4].id | https://openalex.org/C2778810321 |
| concepts[4].level | 4 |
| concepts[4].score | 0.6871274709701538 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q419345 |
| concepts[4].display_name | Dabigatran |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.637188196182251 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C2780645631 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5928021669387817 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q671554 |
| concepts[6].display_name | Stroke (engine) |
| concepts[7].id | https://openalex.org/C197934379 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4499437212944031 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[7].display_name | Adverse effect |
| concepts[8].id | https://openalex.org/C2777288759 |
| concepts[8].level | 2 |
| concepts[8].score | 0.44443243741989136 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q4164182 |
| concepts[8].display_name | Dosing |
| concepts[9].id | https://openalex.org/C2426938 |
| concepts[9].level | 2 |
| concepts[9].score | 0.43009358644485474 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q3355478 |
| concepts[9].display_name | Medical prescription |
| concepts[10].id | https://openalex.org/C2776301958 |
| concepts[10].level | 3 |
| concepts[10].score | 0.356522798538208 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q407431 |
| concepts[10].display_name | Warfarin |
| concepts[11].id | https://openalex.org/C164705383 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3524973392486572 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q10379 |
| concepts[11].display_name | Cardiology |
| concepts[12].id | https://openalex.org/C98274493 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[12].display_name | Pharmacology |
| concepts[13].id | https://openalex.org/C78519656 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q101333 |
| concepts[13].display_name | Mechanical engineering |
| concepts[14].id | https://openalex.org/C127413603 |
| concepts[14].level | 0 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q11023 |
| concepts[14].display_name | Engineering |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.985358476638794 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/apixaban |
| keywords[1].score | 0.9107940196990967 |
| keywords[1].display_name | Apixaban |
| keywords[2].id | https://openalex.org/keywords/rivaroxaban |
| keywords[2].score | 0.8661466836929321 |
| keywords[2].display_name | Rivaroxaban |
| keywords[3].id | https://openalex.org/keywords/atrial-fibrillation |
| keywords[3].score | 0.7471791505813599 |
| keywords[3].display_name | Atrial fibrillation |
| keywords[4].id | https://openalex.org/keywords/dabigatran |
| keywords[4].score | 0.6871274709701538 |
| keywords[4].display_name | Dabigatran |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.637188196182251 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/stroke |
| keywords[6].score | 0.5928021669387817 |
| keywords[6].display_name | Stroke (engine) |
| keywords[7].id | https://openalex.org/keywords/adverse-effect |
| keywords[7].score | 0.4499437212944031 |
| keywords[7].display_name | Adverse effect |
| keywords[8].id | https://openalex.org/keywords/dosing |
| keywords[8].score | 0.44443243741989136 |
| keywords[8].display_name | Dosing |
| keywords[9].id | https://openalex.org/keywords/medical-prescription |
| keywords[9].score | 0.43009358644485474 |
| keywords[9].display_name | Medical prescription |
| keywords[10].id | https://openalex.org/keywords/warfarin |
| keywords[10].score | 0.356522798538208 |
| keywords[10].display_name | Warfarin |
| keywords[11].id | https://openalex.org/keywords/cardiology |
| keywords[11].score | 0.3524973392486572 |
| keywords[11].display_name | Cardiology |
| language | en |
| locations[0].id | doi:10.1016/j.cjca.2019.07.519 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S126162762 |
| locations[0].source.issn | 0828-282X, 1916-7075 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0828-282X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Canadian Journal of Cardiology |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | http://www.onlinecjc.ca/article/S0828282X19310013/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Canadian Journal of Cardiology |
| locations[0].landing_page_url | https://doi.org/10.1016/j.cjca.2019.07.519 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5048925587 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Yana Shamiss |
| authorships[0].countries | CA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[0].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[0].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[0].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[0].institutions[0].type | other |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[0].institutions[0].country_code | CA |
| authorships[0].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Y. Shamiss |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Newmarket, Ontario |
| authorships[1].author.id | https://openalex.org/A5033301387 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-0751-2995 |
| authorships[1].author.display_name | Pouria Alipour |
| authorships[1].countries | CA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[1].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[1].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[1].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[1].institutions[0].type | other |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[1].institutions[0].country_code | CA |
| authorships[1].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | P. Alipour |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Newmarket, Ontario |
| authorships[2].author.id | https://openalex.org/A5033944429 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-7897-0934 |
| authorships[2].author.display_name | Zahra Azizi |
| authorships[2].countries | CA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[2].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[2].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[2].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[2].institutions[0].type | other |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[2].institutions[0].country_code | CA |
| authorships[2].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Z. Azizi |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Newmarket, Ontario |
| authorships[3].author.id | https://openalex.org/A5013884130 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1709-2290 |
| authorships[3].author.display_name | Sarah Donegan |
| authorships[3].countries | CA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[3].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[3].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[3].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[3].institutions[0].type | other |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[3].institutions[0].country_code | CA |
| authorships[3].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | S. Donegan |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Newmarket, Ontario |
| authorships[4].author.id | https://openalex.org/A5020067143 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | N. Varah |
| authorships[4].countries | CA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[4].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[4].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[4].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[4].institutions[0].type | other |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[4].institutions[0].country_code | CA |
| authorships[4].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | N. Varah |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Newmarket, Ontario |
| authorships[5].author.id | https://openalex.org/A5041145038 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Alona Avoulov |
| authorships[5].countries | CA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[5].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[5].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[5].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[5].institutions[0].type | other |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[5].institutions[0].country_code | CA |
| authorships[5].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | A. Avoulov |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Newmarket, Ontario |
| authorships[6].author.id | https://openalex.org/A5113212283 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | S Nath |
| authorships[6].countries | CA |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[6].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[6].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[6].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[6].institutions[0].type | other |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[6].institutions[0].country_code | CA |
| authorships[6].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | S. Nath |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Newmarket, Ontario |
| authorships[7].author.id | https://openalex.org/A5035824620 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8440-3701 |
| authorships[7].author.display_name | Catherine E. Jansen |
| authorships[7].countries | CA |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[7].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[7].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[7].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[7].institutions[0].type | other |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[7].institutions[0].country_code | CA |
| authorships[7].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | C. Jansen |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Newmarket, Ontario |
| authorships[8].author.id | https://openalex.org/A5033800791 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Sara Tamjidi |
| authorships[8].countries | CA |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[8].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[8].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[8].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[8].institutions[0].type | other |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[8].institutions[0].country_code | CA |
| authorships[8].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | S. Tamjidi |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Newmarket, Ontario |
| authorships[9].author.id | https://openalex.org/A5109339803 |
| authorships[9].author.orcid | https://orcid.org/0009-0000-1813-0557 |
| authorships[9].author.display_name | Susan Morris |
| authorships[9].countries | CA |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[9].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[9].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[9].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[9].institutions[0].type | other |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[9].institutions[0].country_code | CA |
| authorships[9].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | S. Morris |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Newmarket, Ontario |
| authorships[10].author.id | https://openalex.org/A5050179181 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Hadi Tohidi |
| authorships[10].countries | CA |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[10].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[10].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[10].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[10].institutions[0].type | other |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[10].institutions[0].country_code | CA |
| authorships[10].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | H. Tohidi |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Newmarket, Ontario |
| authorships[11].author.id | https://openalex.org/A5001969567 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-9711-1257 |
| authorships[11].author.display_name | Howard Lightstone |
| authorships[11].countries | CA |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[11].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[11].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[11].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[11].institutions[0].type | other |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[11].institutions[0].country_code | CA |
| authorships[11].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | H. Lightstone |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Newmarket, Ontario |
| authorships[12].author.id | https://openalex.org/A5058200411 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | A. Shusterman |
| authorships[12].countries | CA |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[12].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[12].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[12].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[12].institutions[0].type | other |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[12].institutions[0].country_code | CA |
| authorships[12].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | A. Shusterman |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Newmarket, Ontario |
| authorships[13].author.id | https://openalex.org/A5005781762 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-8649-0909 |
| authorships[13].author.display_name | Yaariv Khaykin |
| authorships[13].countries | CA |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210087597 |
| authorships[13].affiliations[0].raw_affiliation_string | Newmarket, Ontario |
| authorships[13].institutions[0].id | https://openalex.org/I4210087597 |
| authorships[13].institutions[0].ror | https://ror.org/00314zp94 |
| authorships[13].institutions[0].type | other |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210087597 |
| authorships[13].institutions[0].country_code | CA |
| authorships[13].institutions[0].display_name | Canadian Rheumatology Association |
| authorships[13].author_position | last |
| authorships[13].raw_author_name | Y. Khaykin |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Newmarket, Ontario |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://www.onlinecjc.ca/article/S0828282X19310013/pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | EVALUATION OF NOVEL ORAL ANTICOAGULANT PRESCRIPTION PATTERNS IN A TERTIARY CARE CLINIC |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10065 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9994000196456909 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2705 |
| primary_topic.subfield.display_name | Cardiology and Cardiovascular Medicine |
| primary_topic.display_name | Atrial Fibrillation Management and Outcomes |
| related_works | https://openalex.org/W2093259736, https://openalex.org/W2543625995, https://openalex.org/W2083901189, https://openalex.org/W2134062404, https://openalex.org/W1436836526, https://openalex.org/W1975219299, https://openalex.org/W2046188252, https://openalex.org/W4205842753, https://openalex.org/W4292463656, https://openalex.org/W2015160455 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1016/j.cjca.2019.07.519 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S126162762 |
| best_oa_location.source.issn | 0828-282X, 1916-7075 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0828-282X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Canadian Journal of Cardiology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | http://www.onlinecjc.ca/article/S0828282X19310013/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Canadian Journal of Cardiology |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.cjca.2019.07.519 |
| primary_location.id | doi:10.1016/j.cjca.2019.07.519 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S126162762 |
| primary_location.source.issn | 0828-282X, 1916-7075 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0828-282X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Canadian Journal of Cardiology |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | http://www.onlinecjc.ca/article/S0828282X19310013/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Canadian Journal of Cardiology |
| primary_location.landing_page_url | https://doi.org/10.1016/j.cjca.2019.07.519 |
| publication_date | 2019-10-01 |
| publication_year | 2019 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 14 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8299999833106995 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.19567304 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |